Resolvin d1

Resolvin d1 is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 305 references associated with Resolvin d1 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Resolvin d1

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Resolvin d1

PubChem Biomolecular Interactions and Pathways

All references with Resolvin d1

Download all related citations
Per page 10 20 50 100 | Total 185
Authors Title Published Journal PubMed Link
Lee Y et al. Analysis of endogenous lipids during intestinal wound healing. 2017 PLoS ONE pmid:28800645
Lippestad M et al. Resolvin D1 Increases Mucin Secretion in Cultured Rat Conjunctival Goblet Cells via Multiple Signaling Pathways. 2017 Invest. Ophthalmol. Vis. Sci. pmid:28892824
Mottola G et al. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway. 2017 PLoS ONE pmid:28362840
Eickmeier O et al. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. 2017 PLoS ONE pmid:28158236
Gu Z et al. Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes. 2016 Innate Immun pmid:26878867
Xie W et al. ResolvinD1 reduces apoptosis and inflammation in primary human alveolar epithelial type 2 cells. 2016 Lab. Invest. pmid:26878131
Croasdell A et al. Resolvin D1 Dampens Pulmonary Inflammation and Promotes Clearance of Nontypeable Haemophilus influenzae. 2016 J. Immunol. pmid:26843331
Liu Y et al. Resolvin D1 protects against inflammation in experimental acute pancreatitis and associated lung injury. 2016 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:26702138
Abdulnour RE et al. Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation. 2016 Mucosal Immunol pmid:26647716
Berrueta L et al. Stretching Impacts Inflammation Resolution in Connective Tissue. 2016 J. Cell. Physiol. pmid:26588184
Kim N et al. Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production. 2016 Eur. J. Immunol. pmid:26474728
Benabdoune H et al. The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis. 2016 Inflamm. Res. pmid:27056390
Meesawatsom P et al. Inhibitory effects of aspirin-triggered resolvin D1 on spinal nociceptive processing in rat pain models. 2016 J Neuroinflammation pmid:27589850
Easley JT et al. AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epithelium. 2016 Physiol Rep pmid:27694530
Titos E et al. Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue. 2016 J. Immunol. pmid:27647830
Wang CS et al. ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland. 2016 Sci Rep pmid:27064029
Luo B et al. Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis. 2016 J. Neurosci. pmid:27629711
Kim KH et al. Resolvin D1 prevents smoking-induced emphysema and promotes lung tissue regeneration. 2016 Int J Chron Obstruct Pulmon Dis pmid:27313451
Zhao Q et al. Resolvin D1 Alleviates the Lung Ischemia Reperfusion Injury via Complement, Immunoglobulin, TLR4, and Inflammatory Factors in Rats. 2016 Inflammation pmid:27145782
Zhao YL et al. Resolvin D1 Protects Lipopolysaccharide-induced Acute Kidney Injury by Down-regulating Nuclear Factor-kappa B Signal and Inhibiting Apoptosis. 2016 Chin. Med. J. pmid:27098797
Shi H et al. VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1. 2016 Prostaglandins Other Lipid Mediat. pmid:27026343
Zhao Q et al. Resolvin D1 mitigates energy metabolism disorder after ischemia-reperfusion of the rat lung. 2016 J Transl Med pmid:27009328
Schmid M et al. Resolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32. 2016 J. Immunol. pmid:26969756
Prieto P et al. Activation of autophagy in macrophages by pro-resolving lipid mediators. 2015 Autophagy pmid:26506892
Lehmann C et al. Lipoxin and resolvin biosynthesis is dependent on 5-lipoxygenase activating protein. 2015 FASEB J. pmid:26289316
Hsiao HM et al. Resolvin D1 Reduces Emphysema and Chronic Inflammation. 2015 Am. J. Pathol. pmid:26468975
Maekawa T et al. Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway. 2015 Nat Commun pmid:26374165
Taylan A et al. S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever. 2015 J. Korean Med. Sci. pmid:26339162
Cox R et al. Resolvins Decrease Oxidative Stress Mediated Macrophage and Epithelial Cell Interaction through Decreased Cytokine Secretion. 2015 PLoS ONE pmid:26317859
Croasdell A et al. Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages. 2015 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:26301452
Rossi S et al. Interplay between Intravitreal RvD1 and Local Endogenous Sirtuin-1 in the Protection from Endotoxin-Induced Uveitis in Rats. 2015 Mediators Inflamm. pmid:26180376
de Oliveira JR et al. AT-RvD1 modulates CCL-2 and CXCL-8 production and NF-κB, STAT-6, SOCS1, and SOCS3 expression on bronchial epithelial cells stimulated with IL-4. 2015 Biomed Res Int pmid:26075216
Shevalye H et al. Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes. 2015 J. Neurophysiol. pmid:25925322
Kain V et al. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function. 2015 J. Mol. Cell. Cardiol. pmid:25870158
Fiala M et al. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. 2015 FASEB J. pmid:25805829
Orr SK et al. Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent. 2015 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:25770181
Dalli J et al. Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways. 2015 FASEB J. pmid:25713027
Rossi S et al. Protection from endotoxic uveitis by intravitreal Resolvin D1: involvement of lymphocytes, miRNAs, ubiquitin-proteasome, and M1/M2 macrophages. 2015 Mediators Inflamm. pmid:25684860
Cox R et al. Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment. 2015 Am. J. Respir. Cell Mol. Biol. pmid:25647402
Lastrucci C et al. Molecular and cellular profiles of the resolution phase in a damage-associated molecular pattern (DAMP)-mediated peritonitis model and revelation of leukocyte persistence in peritoneal tissues. 2015 FASEB J. pmid:25609430
Pierdomenico AM et al. MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages. 2015 J. Biol. Chem. pmid:25505240
Wang X et al. Resolution of inflammation is altered in Alzheimer's disease. 2015 Alzheimers Dement pmid:24530025
Lim JY et al. Biological Roles of Resolvins and Related Substances in the Resolution of Pain. 2015 Biomed Res Int pmid:26339646
Hiram R et al. Resolvin E1 normalizes contractility, Ca2+ sensitivity and smooth muscle cell migration rate in TNF-α- and IL-6-pretreated human pulmonary arteries. 2015 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:26320154
Harrison JL et al. Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse. 2015 Brain Behav. Immun. pmid:25585137
Hua J et al. The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation. 2014 Invest. Ophthalmol. Vis. Sci. pmid:25146982
Gilbert K et al. Resolvin D1, a metabolite of omega-3 polyunsaturated fatty acid, decreases post-myocardial infarct depression. 2014 Mar Drugs pmid:25402828
Wales KM et al. N-3 PUFAs protect against aortic inflammation and oxidative stress in angiotensin II-infused apolipoprotein E-/- mice. 2014 PLoS ONE pmid:25398022
Hsiao HM et al. Resolvin D1 attenuates polyinosinic-polycytidylic acid-induced inflammatory signaling in human airway epithelial cells via TAK1. 2014 J. Immunol. pmid:25320283
Hiram R et al. Resolvin D1 reverses reactivity and Ca2+ sensitivity induced by ET-1, TNF-α, and IL-6 in the human pulmonary artery. 2014 Am. J. Physiol. Heart Circ. Physiol. pmid:25281570
Arnardottir HH et al. Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines. 2014 J. Immunol. pmid:25217168
Li L et al. Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells. 2014 J Neuroinflammation pmid:24708771
Martin CR et al. Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury. 2014 PLoS ONE pmid:24892762
Mirakaj V et al. Vagus nerve controls resolution and pro-resolving mediators of inflammation. 2014 J. Exp. Med. pmid:24863066
McCauley LK et al. Cutting edge: Parathyroid hormone facilitates macrophage efferocytosis in bone marrow via proresolving mediators resolvin D1 and resolvin D2. 2014 J. Immunol. pmid:24890726
Yaxin W et al. Resolvin D1 attenuates lipopolysaccharide induced acute lung injury through CXCL-12/CXCR4 pathway. 2014 J. Surg. Res. pmid:24387839
Leigh NJ et al. Expression of resolvin D1 biosynthetic pathways in salivary epithelium. 2014 J. Dent. Res. pmid:24389810
Aursnes M et al. Total synthesis of the lipid mediator PD1n-3 DPA: configurational assignments and anti-inflammatory and pro-resolving actions. 2014 J. Nat. Prod. pmid:24576195
Wang Q et al. Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na,K-ATPase via ALX/cAMP/PI3K pathway in lipopolysaccharide-induced acute lung injury. 2014 J. Immunol. pmid:24646745
Chen J et al. Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury. 2014 Toxicol. Appl. Pharmacol. pmid:24709673
Recchiuti A et al. Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 2014 FASEB J. pmid:24692596
Fredman G et al. Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25246560
Nelson JW et al. ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands. 2014 Am. J. Physiol., Cell Physiol. pmid:24259417
Rius B et al. Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. 2014 FASEB J. pmid:24249635
Shinohara M et al. Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1. 2014 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:25217660
Chen F et al. Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response. 2014 Eur. J. Clin. Microbiol. Infect. Dis. pmid:24072678
Tang H et al. Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury. 2014 J. Immunol. pmid:25172497
Mustafa M et al. Resolvin D1 protects periodontal ligament. 2013 Am. J. Physiol., Cell Physiol. pmid:23864609
Lee HJ et al. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32. 2013 Int. J. Biochem. Cell Biol. pmid:24120851
Mizwicki MT et al. 1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients. 2013 J. Alzheimers Dis. pmid:23186989
Abdelmoaty S et al. Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release. 2013 PLoS ONE pmid:24086560
Hsiao HM et al. A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation. 2013 PLoS ONE pmid:23484005
Tang Y et al. Proresolution therapy for the treatment of delayed healing of diabetic wounds. 2013 Diabetes pmid:23043160
Kurihara T et al. Resolvin D2 restores neutrophil directionality and improves survival after burns. 2013 FASEB J. pmid:23430978
Recchiuti A Resolvin D1 and its GPCRs in resolution circuits of inflammation. 2013 Prostaglandins Other Lipid Mediat. pmid:23500003
Miyahara T et al. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. 2013 FASEB J. pmid:23407709
Lee HN et al. Resolvin D1 stimulates efferocytosis through p50/p50-mediated suppression of tumor necrosis factor-α expression. 2013 J. Cell. Sci. pmid:23788426
Koltsida O et al. Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation. 2013 EMBO Mol Med pmid:23584892
Khaled M et al. Effects of resolvin D1 on cell survival and cytokine expression of human gingival fibroblasts. 2013 J. Periodontol. pmid:23398023
Xu MX et al. Resolvin D1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses. 2013 CNS Neurosci Ther pmid:23521911
Zhang X et al. Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3β acetylation. 2013 PLoS ONE pmid:23840712
Dalli J et al. Novel n-3 immunoresolvents: structures and actions. 2013 Sci Rep pmid:23736886
Sun YB et al. Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney. 2013 PLoS ONE pmid:24391884
Terrando N et al. Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline. 2013 FASEB J. pmid:23709617
Zhang X et al. Resolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating IκBα signaling in human vascular endothelial cells. 2013 Oxid Med Cell Longev pmid:24381712
Lee HN and Surh YJ Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis. 2013 Biochem. Pharmacol. pmid:23856291
Xie W et al. Resolvin D1 reduces deterioration of tight junction proteins by upregulating HO-1 in LPS-induced mice. 2013 Lab. Invest. pmid:23857007
Eickmeier O et al. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. 2013 Mucosal Immunol pmid:22785226
Chung ML et al. Profiling of oxidized lipid products of marine fish under acute oxidative stress. 2013 Food Chem. Toxicol. pmid:23220612
Wu D et al. Novel biphasic role of resolvin D1 on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts is partly through PI3K/AKT and ERK2 pathways. 2013 Mediators Inflamm. pmid:24174713
Li D et al. Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion. 2013 Mucosal Immunol pmid:23462912
Widgerow AD Cellular resolution of inflammation--catabasis. 2012 Jan-Feb Wound Repair Regen pmid:22276585
Odusanwo O et al. Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation. 2012 Am. J. Physiol., Cell Physiol. pmid:22237406
Bang S et al. 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. 2012 Br. J. Pharmacol. pmid:21718307
Jones CN et al. Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:23185003
Norling LV et al. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:22499990
Krishnamoorthy S et al. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. 2012 Am. J. Pathol. pmid:22449948
Liao Z et al. Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. 2012 Respir. Res. pmid:23199346
Chiang N et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. 2012 Nature pmid:22538616
Settimio R et al. Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis. 2012 Mediators Inflamm. pmid:23304060

Table of Content